Eastwood Bio-Medical Canada Inc. reported earnings results for the third quarter and nine months ended July 31, 2022. For the third quarter, the company reported sales was CAD 0.268605 million compared to CAD 0.209418 million a year ago. Revenue was CAD 0.285229 million compared to CAD 0.22524 million a year ago. Net loss was CAD 0.085313 million compared to CAD 0.176159 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the nine months, sales was CAD 0.85536 million compared to CAD 0.662049 million a year ago. Revenue was CAD 0.918852 million compared to CAD 0.710368 million a year ago. Net loss was CAD 0.124916 million compared to CAD 0.598212 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.